Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 998 | 2,537 | 2,627 | 711 | 2,880 |
| Cost of Goods | 501 | 1,550 | 1,411 | 459 | 1,737 |
| Gross Profit | 497 | 987 | 1,216 | 252 | 1,143 |
| Operating Expenses | 10,726 | 9,144 | 8,011 | 7,283 | 6,789 |
| Operating Income | -9,728 | -7,607 | -6,384 | -6,572 | -4,909 |
| Interest Expense | -1,199 | 0 | 602 | 900 | 2,986 |
| Other Income | -1,663 | 1,663 | 0 | 0 | 0 |
| Pre-tax Income | -10,192 | -5,944 | -6,986 | -7,472 | -7,895 |
| Income Tax | -31 | 52 | 57 | 27 | -368 |
| Net Income Continuous | -10,161 | -5,996 | -7,043 | -7,499 | -7,527 |
| Net Income | $-10,161 | $-5,996 | $-7,043 | $-7,499 | $-7,527 |
| EPS Basic Total Ops | -0.49 | -0.29 | -0.35 | -0.37 | -0.41 |
| EPS Basic Continuous Ops | -0.49 | -0.29 | -0.35 | -0.37 | -0.41 |
| EPS Diluted Total Ops | -0.49 | -0.29 | -0.35 | -0.37 | -0.41 |
| EPS Diluted Continuous Ops | -0.49 | -0.29 | -0.35 | -0.37 | -0.41 |
| EBITDA(a) | $-9,232 | $-7,120 | $-5,913 | $-6,147 | $-4,523 |